Mitochondrial haplogroup association with fasting glucose response in African Americans treated with a thiazide diuretic
Open Access
- 26 August 2022
- journal article
- research article
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 758
Abstract
Background: Hypertensive African Americans have a ~50% response rate to thiazide diuretic treatment. This contributes to a high prevalence of uncontrolled high blood pressure. Here, we examined the role of the mitochondrial genome on thiazide diuretic treatment response in hypertensive African Americans enrolled in a clinical trial. Methods: Participants from the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT, n= 4279) were genotyped using the Illumina Infinium Multi-Ethnic Beadchip. Haplotype groups were called using HaploGrep. We used a linear regression analysis to examine the association between mitochondrial haplogroups (L, M, and N) and changes in blood pressure and fasting glucose over six months and two years, respectively. Results: The analysis revealed a null association between mitochondrial haplogroups M and N versus L for each of the outcomes. In subgroup analysis, the L subclades L1, L2, and L3/L4 (versus L0) were each inversely associated with fasting glucose response (p < 0.05). Conclusions: This discovery analysis suggests the mitochondrial genome has a small effect on fasting glucose response, but not that of blood pressure, to thiazide diuretic treatment in African Americans.Keywords
All Related Versions
Funding Information
- National Institutes of Health National Heart, Lung, and Blood Institute (3R01HL123782-02S1)
This publication has 43 references indexed in Scilit:
- Nonsynonymous variants in mt-Nd2, mt-Nd4, and mt-Nd5 are linked to effects on oxidative phosphorylation and insulin sensitivity in rat conplastic strainsPhysiological Genomics, 2012
- Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT StudyJournal Of Hypertension, 2010
- Antihypertensive pharmacogenetic effect of fibrinogen-beta variant −455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT studyPharmacogenetics and Genomics, 2009
- Correcting for Purifying Selection: An Improved Human Mitochondrial Molecular ClockThe American Journal of Human Genetics, 2009
- The causes of mutation accumulation in mitochondrial genomesProceedings Of The Royal Society B-Biological Sciences, 2009
- Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strainsGenome Research, 2007
- Mitochondrial Haplogroup N9a Confers Resistance against Type 2 Diabetes in AsiansThe American Journal of Human Genetics, 2007
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary MedicineAnnual Review of Genetics, 2005
- Effects of Purifying and Adaptive Selection on Regional Variation in Human mtDNAScience, 2004